Results 181 to 190 of about 96,331 (301)

Evaluation of a Cell-Based Potency Assay for Detection of the Potency of TrenibotulinumtoxinE^® (TrenibotE). [PDF]

Toxins (Basel)
Yang Y, Zhang H, Wang S, Xue Y, Yuan L.
europepmc   +1 more source

Clostridium botulinum neurotoxin [PDF]

Microbiological Reviews, 1980
openaire   +2 more sources

Crippling konzo in DRC, three generations later [PDF]

, 2014
Banea Mayambu, Jean-Pierre, Diasolua Ngudi, Delphin, Lambein, Fernand   +2 more
core   +1 more source

From Gut to Systemic Circulation: Molecular Strategies of Botulinum Neurotoxin Complexes. [PDF]

Toxins (Basel)
Mondy J, Lemichez E.
europepmc   +1 more source

Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A. [PDF]

Toxins (Basel)
Al-Sabi A, Lawrence GW.
europepmc   +1 more source

Improved Extraction of the Neurotoxin of <i>Stenocarpella maydis</i> Using an Artificial Rumen. [PDF]

Vet Med Int
Snyman LD.
europepmc   +1 more source

Serum Sickness After Cosmetic Botulinum Toxin Type A Injections. [PDF]

Aesthet Surg J Open Forum
DeLuca-Pytell D, Dass K, Audia G, Busuito E.   +3 more
europepmc   +1 more source

Use of Clotrimazole in Finfish Aquaculture: Mechanistic Insights, Limitations, and Future Directions for Antifungal Therapy

Animal Research and One Health, EarlyView.
This review critically evaluates clotrimazole as a potential antifungal for finfish aquaculture, highlighting strong mechanistic and in vitro efficacy against aquatic mycoses alongside major gaps in in vivo evidence, toxicokinetics, residue safety, and environmental risk, outlining priorities for responsible therapeutic development and regulatory ...
Arya Sen, Debashri Mondal, Thangapalam Jawahar Abraham   +2 more
wiley   +1 more source

Dysphagia After Cosmetic Submandibular Gland Botulinum Neurotoxin Type A Injection: A Case Report. [PDF]

Healthcare (Basel)
Yang S, Yi YG.
europepmc   +1 more source

Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, EarlyView.
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley   +1 more source